| IR |
Report |
Adjusted EPS |
IN-LINE |
pred ~$0.830 vs. cons $0.824 |
MEDIUM |
| IR |
Report |
Revenue |
IN-LINE |
pred ~$1.962B vs. cons $1.958B |
MEDIUM |
| IR |
Report |
Organic revenue growth |
MISS |
pred ~+0.5% vs. cons +0.67% |
MEDIUM |
| IR |
Guide |
FY26 revenue growth |
UNCHANGED |
guide 2.5%-4.5% vs. consensus midpoint implied ~3.0% |
MEDIUM |
| IR |
Guide |
FY26 adjusted EBITDA |
UNCHANGED |
guide $2.130B-$2.190B vs. cons $2.154B |
MEDIUM |
| IR |
Guide |
FY26 adjusted EPS |
UNCHANGED |
guide $3.45-$3.57 vs. cons $3.502 |
MEDIUM |
| IR |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| IR |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — unchanged guidance leaves revisions flat-to-down after an organic-growth miss |
LOW |